A vs ADI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and ADI is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
A’s FA Score shows that 1 FA rating(s) are green whileADI’s FA Score has 3 green FA rating(s).
- A’s FA Score: 1 green, 4 red.
- ADI’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
A’s TA Score shows that 6 TA indicator(s) are bullish while ADI’s TA Score has 6 bullish TA indicator(s).
- A’s TA Score: 6 bullish, 3 bearish.
- ADI’s TA Score: 6 bullish, 2 bearish.
Price Growth
A (@Medical Specialties) experienced а +2.24% price change this week, while ADI (@Semiconductors) price change was +4.08% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +4.26%. For the same industry, the average monthly price growth was -6.64%, and the average quarterly price growth was -2.53%.
The average weekly price growth across all stocks in the @Semiconductors industry was +6.62%. For the same industry, the average monthly price growth was -10.47%, and the average quarterly price growth was -12.66%.
Reported Earning Dates
A is expected to report earnings on May 28, 2025.
ADI is expected to report earnings on May 21, 2025.
Industries' Descriptions
@Medical Specialties (+4.26% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Semiconductors (+6.62% weekly)The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.
| A | ADI | A / ADI | |
| Capitalization | 42.7B | 96.8B | 44% |
| EBITDA | 1.69B | 4.12B | 41% |
| Gain YTD | -21.674 | -13.439 | 161% |
| P/E Ratio | 34.82 | 62.37 | 56% |
| Revenue | 6.74B | 9.34B | 72% |
| Total Cash | N/A | 2.72B | - |
| Total Debt | 2.56B | 7.57B | 34% |
A | ADI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 8 | 14 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 17 Undervalued | 25 Undervalued | |
PROFIT vs RISK RATING 1..100 | 59 | 28 | |
SMR RATING 1..100 | 44 | 84 | |
PRICE GROWTH RATING 1..100 | 65 | 63 | |
P/E GROWTH RATING 1..100 | 78 | 9 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
A's Valuation (17) in the Biotechnology industry is in the same range as ADI (25) in the Semiconductors industry. This means that A’s stock grew similarly to ADI’s over the last 12 months.
ADI's Profit vs Risk Rating (28) in the Semiconductors industry is in the same range as A (59) in the Biotechnology industry. This means that ADI’s stock grew similarly to A’s over the last 12 months.
A's SMR Rating (44) in the Biotechnology industry is somewhat better than the same rating for ADI (84) in the Semiconductors industry. This means that A’s stock grew somewhat faster than ADI’s over the last 12 months.
ADI's Price Growth Rating (63) in the Semiconductors industry is in the same range as A (65) in the Biotechnology industry. This means that ADI’s stock grew similarly to A’s over the last 12 months.
ADI's P/E Growth Rating (9) in the Semiconductors industry is significantly better than the same rating for A (78) in the Biotechnology industry. This means that ADI’s stock grew significantly faster than A’s over the last 12 months.
| A | ADI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 58% | 2 days ago 60% |
| Stochastic ODDS (%) | 2 days ago 60% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 63% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 67% | 2 days ago 57% |
| TrendWeek ODDS (%) | 2 days ago 64% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 63% | 2 days ago 57% |
| Advances ODDS (%) | 2 days ago 62% | 2 days ago 59% |
| Declines ODDS (%) | 4 days ago 60% | 21 days ago 56% |
| BollingerBands ODDS (%) | 2 days ago 63% | 2 days ago 69% |
| Aroon ODDS (%) | 2 days ago 74% | 2 days ago 57% |
